You are currently using an unsupported browser which could affect the appearance and functionality of this website. Please consider upgrading to the latest version or using alternatives such as Mozilla Firefox, Google Chrome or Microsoft Edge.

Sex Steroid Treatment for Pubertal Induction and Replacement in the Adolescent Girl (Scientific Impact Paper No. 40)


Girls with hypogonadism require sex steroid replacement that allows for progression through puberty as in girls with normal gonadal function. Inevitably, many girls presenting with pubertal delay will require a shortened protocol of sex steroid replacement so that their development catches up with their peers. Historically, several forms of estrogen and progesterone have been used for the induction of puberty with the choice being based mainly on local tradition.

The main issues for consideration include the timing of the initiation of estrogen for girls with known estrogen deficiency, the duration of unopposed estrogen to be achieved to mimic normal puberty, possible interference with other pubertal treatment such as growth hormone and the plan for maintenance treatment once adult dose has been achieved.

Sex steroids also have a place for use in eugonadal adolescents for contraception, for the control of menstrual bleeding complaints and to suppress androgen excess in polycystic ovary syndrome (PCOS), but these topics are not within the scope of this paper.

COVID disclaimer

This Scientific Impact Paper was developed prior to the emergence of the COVID-19 coronavirus.

Version history

This is the first edition of this Scientific Impact Paper.

Please note that the Scientific Advisory Committee regularly assesses the need to update. Further information on this review is available on request.

Developer declaration of interests

Available on request.

This page was last reviewed 02 August 2013.